Consistently, OLR1 upregulation was observed in pancreatic cancer tissues and was associated with the poor prognosis of patients, and then OLR1 abrogation caused resistance of pancreatic cancer cells to gemcitabine [9]. Here, OLR1 is linked to pancreatic neoplasm.